Position in AKTS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,293,196
New position
Shares Held
40,124
first reported quarter
Ownership
0.073%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $31,412,059 across 6 Biotechnology names. AKTS ranks #4 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
202,370 | $17,239,900 | |
| 2 | CLDX |
Celldex Therapeutics, Inc.
|
181,054 | $6,737,019 | |
| 3 | IOVA |
Iovance Biotherapeutics, Inc.
|
1,080,288 | $4,493,998 | |
| 4 | AKTS |
Aktis Oncology, Inc.
This page
|
40,124 | $1,293,196 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
4,000 | $979,080 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
905,097 | $668,866 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,293,196 | 40,124 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||